Interleukin -7 (IL-7) Increases Metabolic Thymic and CNS Activity

Interleukin-7 (IL-7) is currently used in a number of clinical trials in humans, including treatment trials for patients with HIV or HCV infection [1]. We would like to draw the attention concerning the impact of IL-7 on the central nervous system (CNS), since most clinical evaluations may not include detailed CNS examination, e.g. Positron Emission Tomography - Computed Tomography (PET-CT) or the evaluation of changes in complex behavior patterns.

Publication type: 
Author or Creator: 
Magalhaes, I.
Sánchez-Crespo, A.
Pagani, Marco
Vudattu, N.K.
Nylen, G.
Halldin, C.
Spångberg, M.
Larsson, S.A.
Spångberg, B.
Maeurer, M.J.
OMICS Publishing Group, Los Angeles, CA , Stati Uniti d'America
Journal of cell science & therapy 3 (2012): 1–3. doi:10.4172/2157-7013.1000127
info:cnr-pdr/source/autori:Magalhaes, I.; Sánchez-Crespo, A.; Pagani, Marco; Vudattu, N.K.; Nylen, G.; Halldin, C.; Spångberg, M.; Larsson, S.A.; Spångberg, B.; Maeurer, M.J./titolo:Interleukin -7 (IL-7) Increases Metabolic Thymic and CNS Activity/doi:10.
Resource Identifier:
ISTC Author: 
Marco Pagani's picture
Real name: